相关实验视频
Updated: May 5, 2026

10:18
In Vivo Gene Transfer to the Rabbit Common Carotid Artery Endothelium
Published on: May 6, 2018
9.0K
输送VEGF基因到心肌:不受管制的表达的有害影响
R J Lee1, M L Springer, W E Blanco-Bose
1Department of Medicine and the Cardiovascular Research Institute, University of California, San Francisco, USA. lee@ep4.ucsf.edu
Circulation
|August 23, 2000
概括
在小鼠中,通过肌肉细胞的输送,血管内皮生长因子 (VEGF) 的持续表达导致显著的死亡率和血管瘤的发展. 这凸显了在治疗性血管生成中对受控VEGF输送的关键需求.
科学领域:
- 心血管研究研究心血管研究
- 基因治疗 基因治疗
- 再生医学是一种再生医学.
背景情况:
- 血管内皮生长因子 (VEGF) 在缺血性心脏病中被用于治疗性血管生成.
- 目前的研究主要集中在VEGF的暂时输送系统上.
- 这项研究研究了使用肌细胞介导输送的连续VEGF表达.
研究的目的:
- 为了评估连续VEGF表达在心肌中的影响.
- 评估肌细胞介导VEGF输送的安全性和有效性.
主要方法:
- 设计以表达VEGF和β-galactosidase的小鼠肌细胞被植入免疫缺陷小鼠体内.
- 对照小鼠接受了只表达β-银酸酶的髓细胞.
- 通过组织学和免疫组织化学分析心脏.
主要成果:
- 在实验组中,持续的VEGF表达导致了成长失败和死亡率.
- 组织学揭示了植入部位的内壁血管瘤,类似于植入部位的血管瘤.
- 在观察到的病变中,内皮细胞标记物 (eNOS,CD31) 非常丰富.
结论:
- 不调节的,连续的VEGF表达与不良结果有关,包括死亡和瘤形成.
- 这些发现强调了调节VEGF表达的必要性,以确保安全的治疗血管生成.
- 肌细胞介导的VEGF输送需要仔细控制,以防止有害影响.
相关概念视频
Gene Therapy
22.1K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
22.1K
Regulation of Angiogenesis and Blood Supply
2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K
Cardiomyopathy II: Dilated Cardiomyopathy
790
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
790
Cardiomyopathy III: Hypertrophic Cardiomyopathy
805
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
805
Cardiomyopathy IV: Restrictive Cardiomyopathy
952
Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
952

